Literature DB >> 9862642

Intraneuronal ApoE in human visual cortical areas reflects the staging of Alzheimer disease pathology.

G Einstein1, V Patel, P Bautista, M Kenna, L Melone, R Fader, K Karson, S Mann, A M Saunders, C Hulette, D Mash, A D Roses, D E Schmechel.   

Abstract

Alzheimer disease (AD) is marked by progressive loss of cortical neurons with associated cognitive decline. Multiple genetic and environmental factors likely contribute to this progressive loss. Such genetic factors include the polymorphic locus (APOE) that encodes apolipoprotein E (apoE). In order to investigate a possible correspondence between cellular localization of apoE and the neuropathology of AD, we examined the distribution of apoE-immunoreactive neurons in visual cortical areas with different apparent susceptibility to AD neuropathology (areas 17-primary sensory, 18-secondary sensory, and inferior temporal-association cortex) at different stages of AD pathology as described by Braak and Braak. We found that intraneuronal apoE was present at all these stages, however, only in visual cortical regions known to be vulnerable to AD. In the late stages, the laminar distribution of apoE-immunoreactivity matched the distribution of other markers of AD pathology, especially modified tau. These data support previous findings that intraneuronal apoE in neocortex is common in aged, nondemented controls and demonstrate that it may be more common in regions at risk for AD pathology. Thus, intraneuronal accumulation of apoE may be an attribute of cortical neurons that are more vulnerable to age-related injury with the presence of apoE antedating the classical indices of late-onset AD pathology.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9862642     DOI: 10.1097/00005072-199812000-00011

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  4 in total

1.  Expression of human apolipoprotein E4 in neurons causes hyperphosphorylation of protein tau in the brains of transgenic mice.

Authors:  I Tesseur; J Van Dorpe; K Spittaels; C Van den Haute; D Moechars; F Van Leuven
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

2.  Human APOE genotype affects intraneuronal Aβ1-42 accumulation in a lentiviral gene transfer model.

Authors:  Wenjuan Zhao; Sonya B Dumanis; Irfan Y Tamboli; Gustavo A Rodriguez; Mary Jo Ladu; Charbel E H Moussa; G William Rebeck
Journal:  Hum Mol Genet       Date:  2013-10-23       Impact factor: 6.150

3.  Prominent axonopathy and disruption of axonal transport in transgenic mice expressing human apolipoprotein E4 in neurons of brain and spinal cord.

Authors:  I Tesseur; J Van Dorpe; K Bruynseels; F Bronfman; R Sciot; A Van Lommel; F Van Leuven
Journal:  Am J Pathol       Date:  2000-11       Impact factor: 4.307

4.  Apolipoprotein E Proteinopathy Is a Major Dementia-Associated Pathologic Biomarker in Individuals with or without the APOE Epsilon 4 Allele.

Authors:  Jozsef Gal; Yuriko Katsumata; Haining Zhu; Sukanya Srinivasan; Jing Chen; Lance Allen Johnson; Wang-Xia Wang; Lesley Renee Golden; Donna M Wilcock; Gregory A Jicha; Matthew D Cykowski; Peter Tobias Nelson
Journal:  Am J Pathol       Date:  2021-12-24       Impact factor: 4.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.